Drug intelligence / Profile preview

Choice DM

Development stage: Unknown
Lead developer: Otsuka Holdings
Administration: Oral, Enteral

Overview

Choice DM is a specialized enteral nutritional formula (medical food) developed for the dietary management of individuals with diabetes mellitus. Produced by Thai Otsuka Pharmaceutical, it is available in two versions: Choice DM Adult for individuals over 12 years of age and Choice DM Junior for children aged 1 to 12 years. The formula is high in protein, utilizing a combination of casein and soy protein, and provides a balanced distribution of carbohydrates, fats, vitamins, and minerals. It is specifically designed to support healthy weight gain or maintenance in diabetic patients who are underweight or at risk of malnutrition, while providing a nutritional profile suitable for blood glucose management. It is typically administered orally or via enteral feeding tubes.

Brand names: Choice DMChoice DM AdultChoice DM Junior

Beyond the preview

Go deeper on Choice DM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Choice DM.

Explore the full profile